Publications found:
345
Sort by:
Antispasmodics Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Dicyclomine Hydrochloride, Loperamide Hydrochloride, Other Drugs), By Indication (Irritable Bowel Syndrome, Stomach Cramps, Other Indications), By Route Of Administration, By Distribution Channel, By End-User
US$ 3,950.00
The Antispasmodics Drugs Market is valued at USD 12.8 billion in 2025 and is projected to grow at a CAGR of 10% to reach USD 30.2 billion by 2034.The Antispasmodics Drugs Market focuses on the develop...
October 2025
160 pages
Arthritis Monoclonal Antibodies Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications), By End-Use
US$ 3,950.00
The Arthritis Monoclonal Antibodies Market is valued at USD 58.7 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 112.4 billion by 2034.The arthritis monoclonal antibodies marke...
October 2025
160 pages
Complicated Skin And Skin Structure Infections Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Linezolid, Other Active Ingredients), By Route of Administration (Oral, Topical, Parenteral), By End User
US$ 3,950.00
The Complicated Skin And Skin Structure Infections Drugs Market is valued at USD 9.1 billion in 2025 and is projected to grow at a CAGR of 12.2% to reach USD 25.7 billion by 2034.The complicated skin...
October 2025
160 pages
Glycopeptide Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication, By End-User
US$ 3,950.00
The Glycopeptide Antibiotics Market is valued at USD 4.7 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 9.7 billion by 2034. Glycopeptide Antibiotics Market Overview The glyco...
October 2025
160 pages
Proton Pump Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole, Other Types), By Disease Allocation (Ulcers, Gastroesophageal Reflux Disease, Other Disease Indications), By Application
US$ 3,950.00
The Proton Pump Inhibitors Market is valued at USD 4.1 billion in 2025 and is projected to grow at a CAGR of 4.6% to reach USD 6.1 billion by 2034. Proton Pump Inhibitors Market Overview The proton pu...
October 2025
160 pages
Psoriasis Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication, By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Psoriasis Market is valued at USD 24.4 billion in 2025 and is projected to grow at a CAGR of 12.5% to reach USD 70.7 billion by 2034. Psoriasis Market Overview The psoriasis market encompasses a w...
October 2025
160 pages
Throat Lozenges Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Hard Candy Lozenges, Soft Lozenges, Compressed Lozenges), By Ingredient (Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey And Ginger, Lemon, Other Ingredients), By Distribution Channel, By Application
US$ 3,950.00
The Throat Lozenges Market is valued at USD 6.8 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 11 billion by 2034.The Throat Lozenges Market continues to be a staple within th...
October 2025
160 pages
Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration, By Drug Classification, By Mode Of Purchase
US$ 3,950.00
The Anti-Infective Drugs Market is valued at USD 161.4 billion in 2025 and is projected to grow at a CAGR of 6.1% to reach USD 274.1 billion by 2034.The Anti-Infective Drugs Market focuses on the deve...
October 2025
160 pages
Barrett'S Esophagus Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types), By Treatment (Medication, Endoscopic Therapy, Surgery, Other Treatments), By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Barrett'S Esophagus Market is valued at USD 8 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 12.5 billion by 2034. Barrett’s Esophagus Market Overview The Barrett’s esopha...
October 2025
160 pages
Cough And Cold Preparations Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drug Types), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types), By Distribution Channel
US$ 3,950.00
The Cough And Cold Preparations Market is valued at USD 72.9 billion in 2025 and is projected to grow at a CAGR of 5.4% to reach USD 116.5 billion by 2034.The global cough and cold preparations market...
October 2025
160 pages
Crohn'S Disease Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application
US$ 3,950.00
The Crohn'S Disease Treatment Market is valued at USD 11.8 billion in 2025 and is projected to grow at a CAGR of 6.9% to reach USD 21.4 billion by 2034.The Crohn’s Disease treatment market continues t...
October 2025
160 pages
Dermatitis Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application
US$ 3,950.00
The Dermatitis Market is valued at USD 8.2 billion in 2025 and is projected to grow at a CAGR of 5.8% to reach USD 13.6 billion by 2034.The Dermatitis Market focuses on the diagnosis and treatment of...
October 2025
160 pages
Dermatology Otc Medications Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Tablets And Capsules, Oils Gels, Creams And Ointments, Other Types), By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, Wart Remover, Other Indications), By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Dermatology Otc Medications Market is valued at USD 14.1 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 21.4 billion by 2034.The Dermatology OTC Medications Market encompa...
October 2025
160 pages
Exocrine Pancreatic Insufficiency (Epi) Therapeutics And Diagnostics Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapies (Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications Approach), By Diagnostics (Blood Tests, Magnetic Resonance Imaging (MRI), Endoscopic Ultra-Sonography (EUS), Computerized Tomography (CT) Scanning), By Drug Type, By Distribution Channel, By End User
US$ 3,950.00
The Exocrine Pancreatic Insufficiency (Epi) Therapeutics And Diagnostics Market is valued at USD 7.2 billion in 2025 and is projected to grow at a CAGR of 8.8% to reach USD 15.4 billion by 2034. Exocr...
October 2025
160 pages
Gastroesophageal Reflux Disease (Gerd) Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)), By Procedure (Invasive, Minimally Invasive), By End-Users
US$ 3,950.00
The Gastroesophageal Reflux Disease (Gerd) Market is valued at USD 6.2 billion in 2025 and is projected to grow at a CAGR of 1.7% to reach USD 7.2 billion by 2034. Gastroesophageal Reflux Disease (GER...
October 2025
160 pages
Gastroesophageal Reflux Disease Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Branded, Generic), By Drug Class (Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class), By Distribution Channel, By Application
US$ 3,950.00
The Gastroesophageal Reflux Disease Therapeutics Market is valued at USD 7.6 billion in 2025 and is projected to grow at a CAGR of 3.2% to reach USD 10.1 billion by 2034. Gastroesophageal Reflux Disea...
October 2025
160 pages
Gastroparesis Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Over-the-counter (OTC) Drugs, Prescription Drugs), By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes), By Disease Type, By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Gastroparesis Drugs Market is valued at USD 6.7 billion in 2025 and is projected to grow at a CAGR of 6.7% to reach USD 12 billion by 2034. Gastroparesis Drugs Market Overview The Gastroparesis Dr...
October 2025
160 pages
Gaucher’S Disease Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, Other Types), By Diagnosis (Physical Exam, Blood Tests, Imaging Tests, Preconception Screening and Prenatal Testing, Other Diagnoses), By Therapy, By Route Of Administration, By End User
US$ 3,950.00
The Gaucher’S Disease Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 6.5% to reach USD 3.7 billion by 2034. Gaucher’s Disease Market Overview The Gaucher’s Disease M...
October 2025
160 pages
Generic Musculoskeletal Disorders Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration, By Distribution Channel
US$ 3,950.00
The Generic Musculoskeletal Disorders Drugs Market is valued at USD 83.1 million in 2025 and is projected to grow at a CAGR of 6.2% to reach USD 142.7 million by 2034. Generic Musculoskeletal Disorder...
October 2025
160 pages
Hepatitis Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase/NS5A Inhibitor Combinations, Hepatitis C Protease/NS5A Inhibitor Combinations, NS5A Inhibitors, Nucleotide Polymerase Inhibitors, Nucleoside Analogue Antivirals, Thrombopoiesis Stimulating Agents), By Route Of Administration (Oral, Injection), By Distribution Channel, By Application
US$ 3,950.00
The Hepatitis Drugs Market is valued at USD 18.5 billion in 2025 and is projected to grow at a CAGR of 5% to reach USD 28.7 billion by 2034.The Hepatitis Drugs Market is experiencing a transformative...
October 2025
160 pages
Herbal Medicine Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Capsules And Tablets, Powders, Extracts, Syrups, Other Products), By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements, Herbal Beauty Products), By Distribution Channel, By Application
US$ 3,950.00
The Herbal Medicine Market is valued at USD 195.6 billion in 2025 and is projected to grow at a CAGR of 11.2% to reach USD 508.9 billion by 2034.The global herbal medicine market has gained substantia...
October 2025
160 pages
Herpangina Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Topical Anesthetics, Ibuprofen Or Acetaminophen, Other Treatments), By Virus (Coxsackie Virus A, Coxsackie Virus B, Enterovirus 71, Echovirus), By Symptoms, By End User
US$ 3,950.00
The Herpangina Treatment Market is valued at USD 2.5 billion in 2025 and is projected to grow at a CAGR of 7.7% to reach USD 4.9 billion by 2034.The Herpangina Treatment Market is gaining significant...
October 2025
160 pages
Homeopathy Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Dilutions, Tinctures, Biochemics, Ointments, Tablets, Other Types), By Source (Plants, Animals, Minerals), By Distribution Channel, By Application
US$ 3,950.00
The Homeopathy Market is valued at USD 12.2 billion in 2025 and is projected to grow at a CAGR of 15% to reach USD 43 billion by 2034.The global homeopathy market has grown steadily in recent years, d...
October 2025
160 pages
Immunosuppressants Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel
US$ 3,950.00
The Immunosuppressants Market is valued at USD 28.3 billion in 2025 and is projected to grow at a CAGR of 15.2% to reach USD 101 billion by 2034.The Immunosuppressants Market is critical to the treatm...
October 2025
160 pages
Irritable Bowel Syndrome (Ibs) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel, By End-Users
US$ 3,950.00
The Irritable Bowel Syndrome (Ibs) Treatment Market is valued at USD 3.8 billion in 2025 and is projected to grow at a CAGR of 10% to reach USD 9 billion by 2034.The Irritable Bowel Syndrome (IBS) Tre...
October 2025
160 pages
Janus Kinase (Jak) Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Inhibitors Type (Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, Other Inhibitor Types), By Mode Of Administration (Injectable, Oral, Other Modes Of Administration), By Distribution Channel, By Application
US$ 3,950.00
The Janus Kinase (Jak) Inhibitors Market is valued at USD 20.7 billion in 2025 and is projected to grow at a CAGR of 20.6% to reach USD 112 billion by 2034.The Janus Kinase (JAK) Inhibitors Market is...
October 2025
160 pages
Ketolides Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Telithromycin, Cethromycin, Solithromycin), By Indication (Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis), By Microorganism, By Distribution Channel
US$ 3,950.00
The Ketolides Market is valued at USD 4.1 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 6.6 billion by 2034.The Ketolides Market comprises a class of antibiotics structurally...
October 2025
160 pages
Lysosomal Disease Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Disease Type (Mucopolysaccharidosis, Pompe Syndrome, Fabry Diseases, Gaucher's Disease, Other Disease Types), By Therapy (Substrate Reduction Therapy, Stem Cell Therapy, Enzyme Replacement Therapy, Other Therapies), By Route Of Administration, By End User
US$ 3,950.00
The Lysosomal Disease Treatment Market is valued at USD 8.8 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 16.7 billion by 2034.The lysosomal disease treatment market addresse...
October 2025
160 pages
Malaria Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments), By Route of Administration (Oral, Parenteral, Intravenous), By Distribution Channel, By End User
US$ 3,950.00
The Malaria Treatment Market is valued at USD 2 billion in 2025 and is projected to grow at a CAGR of 5.8% to reach USD 3.3 billion by 2034.The malaria treatment market encompasses a broad range of an...
October 2025
160 pages
Male Hypogonadism Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types), By Drug Delivery (Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries), By Therapy
US$ 3,950.00
The Male Hypogonadism Market is valued at USD 4.9 billion in 2025 and is projected to grow at a CAGR of 7.1% to reach USD 9.1 billion by 2034.The male hypogonadism market encompasses diagnostic tools...
October 2025
160 pages
